Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,585,673
+$5,826,392 QoQ
Shares Held
175,764
+26.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#491
of 3,769 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vident Advisory, LLC holds $305,361,582 across 15 Drug Manufacturers - General names. MRK ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
70,087 | $84,064,454 | |
| 2 | JNJ |
Johnson & Johnson
|
208,589 | $52,975,346 | |
| 3 | ABBV |
AbbVie Inc.
|
188,691 | $47,482,201 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
225,823 | $28,530,472 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
175,764 | $22,585,673 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
242,261 | $13,959,076 | |
| 7 | AMGN |
Amgen Inc
|
37,277 | $13,498,744 | |
| 8 | SNY |
Sanofi
|
302,447 | $12,902,388 |
All Filings in MRK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,585,673 | 175,764 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,759,281 | 139,324 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,605,904 | 129,260 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $10,044,907 | 119,682 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,868,351 | 137,296 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,846,345 | 131,978 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,403,184 | 154,837 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $25,458,107 | 224,182 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,425,401 | 148,832 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,238,837 | 145,804 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $19,038,597 | 174,634 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,035,295 | 175,185 | Shares | Sole | 2024-02-21 | |
| No filing history on record for this holder in this stock. | ||||||